Therefore, in tumor research, focusing on the regulation of NMDA receptors and mGluR1 on tumors and their mechanisms may be more helpful in developing new therapeutic strategies and biomarkers, thereby improving the efficacy of cancer diagnosis and therapy. Here, GRM1 is linked to neoplasm.